Domain 5 of CD163 for use in antiviral compositions against PRRS, and transgenic animals
US9854790B2 · kind B2 · utility
4Cited by
2References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 24, 2014 |
| Grant date | Jan 2, 2018 |
| Priority date | — |
| Expiry date | Jul 24, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2800/80
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods and compositions useful for the prevention and/or treatment of PRRS in animals, typically domestic pigs. The invention relates to proteins which comprise fragments of CD163, nucleic acid constructs encoding such proteins, and methods of modifying expression or activity of CD 163 in vivo.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.